Genesis Drug Discovery & Development (GD3)
Genesis Drug Discovery and Development (GD3) is a preclinical CRO offering a comprehensive portfolio of services to ensure the efficient development and coordination of unique preclinical programs, from discovery through candidate selection. Services include advanced in vivo testing capabilities in biochemical & molecular biology, creation and testing of patient-derived cancer xenograft models, synthetic organic, & medicinal chemistry, and small molecule drug target validation.